[
    {
        "id": "New-v26-7a9b8c0d-4e2f-41a3-b456-789012345678",
        "type": "highlight",
        "stem": "The patient is exhibiting signs of acute respiratory distress syndrome (ARDS). Review the physician's orders and patient data below. Highlight the findings that support the diagnosis of ARDS.",
        "scoring": {
            "method": "polytomous",
            "maxPoints": 4
        },
        "itemContext": {
            "patient": {
                "name": "John Smith",
                "age": 62,
                "gender": "Male",
                "iso": "Airborne Isolation",
                "allergies": [
                    "Penicillin"
                ]
            },
            "sbar": "S: John Smith, a 62-year-old male, admitted three days prior for pneumonia, is exhibiting increased work of breathing. At 07:00, he showed signs of respiratory distress, including accessory muscle use and nasal flaring. B: He has a history of COPD and is a current smoker with a significant pack-year history. Initially treated with antibiotics for pneumonia, he showed some improvement, but his respiratory status has deteriorated rapidly over the past 12 hours. O: At 07:00, vital signs include SpO2 of 88% on 6L nasal cannula, respiratory rate of 32 breaths per minute, heart rate of 120 beats per minute, and blood pressure of 100/60 mmHg. Auscultation reveals coarse crackles bilaterally. An arterial blood gas (ABG) shows pH 7.30, PaCO2 55 mmHg, PaO2 55 mmHg, and HCO3 24 mEq/L. A recent chest X-ray (CXR) reveals bilateral infiltrates. A: Possible ARDS superimposed on pneumonia and COPD. Refractory hypoxemia, hypercapnia, and bilateral infiltrates are concerning. P: Requesting immediate orders for intubation and mechanical ventilation. Recommend increasing FiO2 prior to intubation. Notify the attending physician immediately to discuss the patient's critical condition and further management strategies. Rule out other potential causes, but ARDS is the primary concern.",
            "tabs": [
                {
                    "id": "labs",
                    "title": "Labs",
                    "content": "<table><thead><tr><th>Lab</th><th>Value</th><th>Normal Range</th></tr></thead><tbody><tr><td>pH</td><td>7.30</td><td>7.35-7.45</td></tr><tr><td>PaCO2</td><td>55 mmHg</td><td>35-45 mmHg</td></tr><tr><td>PaO2</td><td>55 mmHg</td><td>80-100 mmHg</td></tr><tr><td>HCO3</td><td>24 mEq/L</td><td>22-26 mEq/L</td></tr><tr><td>WBC</td><td>15,000/uL</td><td>4,500-11,000/uL</td></tr><tr><td>Lactate</td><td>2.8 mmol/L</td><td>0.5-2.2 mmol/L</td></tr></tbody></table>"
                },
                {
                    "id": "vitals",
                    "title": "Vitals",
                    "content": "<table><thead><tr><th>Time</th><th>BP</th><th>HR</th><th>RR</th><th>SpO2</th><th>Temp</th></tr></thead><tbody><tr><td>06:00</td><td>110/70</td><td>110</td><td>28</td><td>92% (6L NC)</td><td>37.8°C</td></tr><tr><td>07:00</td><td>100/60</td><td>120</td><td>32</td><td>88% (6L NC)</td><td>37.9°C</td></tr><tr><td>08:00</td><td>95/55</td><td>125</td><td>34</td><td>85% (6L NC)</td><td>38.0°C</td></tr></tbody></table>"
                },
                {
                    "id": "cxr",
                    "title": "CXR Report",
                    "content": "CXR reveals bilateral diffuse infiltrates consistent with pulmonary edema or ARDS. No pneumothorax identified."
                },
                {
                    "id": "mar",
                    "title": "MAR",
                    "content": "<table><thead><tr><th>Medication</th><th>Dosage</th><th>Route</th><th>Frequency</th></tr></thead><tbody><tr><td>Ceftriaxone</td><td>1g</td><td>IV</td><td>q12h</td></tr><tr><td>Albuterol</td><td>2.5mg</td><td>Neb</td><td>q4h PRN</td></tr><tr><td>Ipratropium</td><td>0.5mg</td><td>Neb</td><td>q4h PRN</td></tr><tr><td>Furosemide</td><td>20mg</td><td>IV</td><td>BID</td></tr></tbody></table>"
                },
                {
                    "id": "orders",
                    "title": "Orders",
                    "content": "1. Ceftriaxone 1g IV q12h.\n2. Albuterol 2.5mg Neb q4h PRN.\n3. Ipratropium 0.5mg Neb q4h PRN.\n4. Furosemide 20mg IV BID.\n5. Oxygen 6L via nasal cannula.\n6. Continuous cardiac monitoring.\n7. Monitor respiratory status q1h.\n8. Obtain ABG stat.\n9. CXR stat.\n10. Consult pulmonary."
                }
            ]
        },
        "pedagogy": {
            "bloomLevel": "Analyze",
            "cjmmStep": "Evaluate",
            "nclexCategory": "Physiological Integrity",
            "difficulty": 5,
            "topicTags": [
                "Respiratory: Respiratory Failure & ARDS"
            ]
        },
        "rationale": {
            "correct": "A PaO2 of 55 mmHg on 6L of nasal cannula indicates refractory hypoxemia, a hallmark of ARDS. In ARDS, oxygen therapy alone is insufficient to maintain adequate oxygenation due to alveolar damage and impaired gas exchange. A PaCO2 of 55 mmHg indicates hypercapnic respiratory failure, suggesting the patient cannot effectively eliminate carbon dioxide. Bilateral diffuse infiltrates on the CXR are consistent with pulmonary edema and alveolar damage seen in ARDS, indicating widespread inflammation and fluid leakage into the alveoli. An increased respiratory rate of 32 indicates the body's attempt to compensate for hypoxemia and hypercapnia by increasing minute ventilation. An ABG pH of 7.30 indicates respiratory acidosis due to CO2 retention, further supporting the diagnosis of respiratory failure.",
            "incorrect": "An elevated WBC (15,000/uL) suggests infection, but it's not specific to ARDS, although infection can be a cause. ARDS is characterized by an overwhelming inflammatory response, which may or may not be triggered by infection. Ceftriaxone is treatment for the underlying infection, not ARDS itself. While addressing the underlying infection is important, it does not directly address the ARDS pathology. Furosemide addresses fluid overload; while possibly present, it isn't a primary ARDS diagnostic criterion. ARDS is characterized by increased permeability of the alveolar-capillary membrane, leading to pulmonary edema, but diuretics are not the primary treatment. An increased HR of 120 is a non-specific indicator of distress and compensation for hypoxemia and hypercapnia but is not specific enough to ARDS. Tachycardia is a common response to hypoxemia and increased metabolic demand but does not confirm ARDS.",
            "clinicalPearls": [
                "ARDS diagnosis requires: acute onset, bilateral infiltrates on CXR not fully explained by heart failure/fluid overload, and PaO2/FiO2 ratio < 300. The Berlin definition provides specific criteria for ARDS diagnosis.",
                "Refractory hypoxemia is key: oxygenation does not improve with increasing FiO2. This is due to the alveolar-capillary membrane damage and intrapulmonary shunting."
            ],
            "questionTrap": {
                "trap": "Focusing solely on the pneumonia history might lead to overlooking the ARDS development. Students may incorrectly assume the patient's condition is solely due to worsening pneumonia and not recognize the evolving ARDS picture.",
                "howToOvercome": "Carefully evaluate all data points, including lab values, CXR, and vital signs, to identify patterns consistent with ARDS, differentiating it from simple pneumonia progression. Look for the constellation of findings that define ARDS."
            },
            "mnemonic": {
                "title": "ARDS Criteria (Berlin)",
                "expansion": "Acute onset, Respiratory Distress, Bilateral infiltrates, Severe hypoxemia (PaO2/FiO2 <300)."
            }
        },
        "response": {
            "correct": [
                "PaO2",
                "PaCO2",
                "CXR reveals bilateral diffuse infiltrates",
                "RR"
            ],
            "incorrect": [
                "WBC",
                "Ceftriaxone",
                "Furosemide",
                "HR"
            ]
        }
    }
]